Indeed, upregulation of MYC-mediated de novo purine synthesis maintained self-renewal, proliferation and tumor forming capacity in brain TICs, and was associated with poor prognosis in glioblastoma patients (Wang et al., 2017c). This evidence concerns the gene MYC and neoplasm.